Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.


  • Physical activity linked to better memory among older adults

  • Mosquito-borne virus may lead to severe brain infection

  • Marijuana dependence influenced by genes, childhood sexual abuse

  • Thinking of bagging yourself a Black Friday bargain?

  • Synapse discovery could lead to new treatments for Alzheimer's disease

  • And when the bubbles burst, thunder in neurons

  • Better detection of concussion in young football players

  • Structural brain connectivity as a genetic marker for schizophrenia

  • Peak-end pizza: Higher prices mean first impressions count

  • Can physical exercise enhance long-term memory?